AlphaMaven AlphaMaven

MegaRobo Technologies Secures Nearly $200M Financing to Build Real-World Oriented AI Intelligent Infrastructure | 36Kr Exclusive

Reported by 36Kr
Nov 19, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • MegaRobo Technologies has completed a new financing round of nearly $200 million, according to 36Kr, bringing its total accumulated financing to nearly $600 million.
  • • Oman Investment Authority, the sovereign wealth fund of the Sultanate of Oman, participated in the round alongside existing shareholders Asia Investment Capital, Granite Asia and Sinovation Ventures.
  • • Follow-on investors include CMB International, Suzhou Venture Capital and Sanjiang Investment Promotion Group, per the report.
  • • The company reported 1.5 billion RMB in hand orders as of June 2025, according to its Hong Kong Stock Exchange listing prospectus filed that month.
  • • MegaRobo's Kunpeng Lab, now at version 4.0, has advanced 31 drug R&D pipelines within 7 months and serves more than 500 scientific intelligence customers.
Summary
MegaRobo Technologies has recently completed a new round of financing of nearly $200 million, according to 36Kr. The round includes participation from the Oman Investment Authority (OIA), the sovereign wealth fund of the Sultanate of Oman, with additional investment from existing shareholders Asia Investment Capital, Granite Asia and Sinovation Ventures. Follow-on investment came from CMB International, Suzhou Venture Capital and Sanjiang Investment Promotion Group, bringing together international sovereign capital, financial capital and local state-owned industrial capital. The company has raised nearly $600 million in total financing over the ten years since its founding.

The report frames the financing against a broader challenge in AI for Science (AI4S): large-scale, high-quality, reusable scientific data remains scarce, and most life science laboratories in China lack equipment and consumables capable of generating data at scale with consistent quality. HUANG Yuqing, founder and CEO of MegaRobo, described this as a contradiction between growing scientist demand for data and relatively backward productivity. According to the article, a prospectus filed with the Hong Kong Stock Exchange in June 2025 showed 1.5 billion RMB in hand orders as of that month.

The company's flagship platform, the MegaRobo Kunpeng Lab, was launched as a "data factory for the life science industry" with a 1.0 version operating from 2021 and now iterated to 4.0. The company describes version 4.0 as shifting from automated execution to autonomous agent-driven discovery, with separate dry lab and wet lab "brains" and a scheduling agent directing robotic arms. The platform reportedly completed large-scale advancement of 31 drug R&D pipelines within seven months. MegaRobo's business spans scientific intelligence, serving more than 500 customers including multinational pharmaceutical companies, CROs, biotech firms and research institutions, and industrial intelligence focused on semiconductors, optical interconnection and new displays.

According to the report, MegaRobo plans to use the new capital to expand core technology R&D and global business, with cooperation targeted at China, Europe, North America, the Middle East and Southeast Asia. HUANG Yuqing said the company aims to build the infrastructure that enables AI to generate new knowledge, materials, processes and products through experimentation and continuous feedback at scale.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

36Kr MegaRobo Technologies Secures Nearly $200M Financing to Build Real-World Oriented AI Intelligent Infrastructure | 36Kr Exclusive